Belatacept-Based Immunosuppression in De Novo Liver Transplant Recipients: 1-Year Experience From a Phase II Randomized Study

por Klintmalm, G B, Feng, S, Lake, J R, Vargas, H E, Wekerle, T, Agnes, S, Brown, K A, Nashan, B, Rostaing, L, Meadows-Shropshire, S, Agarwal, M, Harler, M B, García-Valdecasas, J-C
Publicado 2014